sulfisoxazole has been researched along with amphotericin b in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bondock, S; Eid, S; Nasr, T | 1 |
| AbdelAziz, NA; Bondock, S; Fayad, W; Ibrahim, AB; Ibrahim, TM; Nasr, T; Sakr, TM | 1 |
| Betts, RF; Douglas, RG; Jacox, RF; Morris, RJ | 1 |
| Lara, R | 1 |
| Kagan, BM; Levin, HS | 1 |
| Duma, RJ; Markowitz, SM; Martinez, AJ; Shiel, FO | 1 |
| Monteforte, JS; Wood, CA | 1 |
9 other study(ies) available for sulfisoxazole and amphotericin b
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus; Bacillus subtilis; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Pyrazoles; Pyridones; Structure-Activity Relationship; Sulfisoxazole; Thiophenes | 2014 |
New acrylamide-sulfisoxazole conjugates as dihydropteroate synthase inhibitors.
Topics: Acrylamide; Anti-Bacterial Agents; Cells, Cultured; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Sulfisoxazole | 2020 |
Recurrent disseminated histoplasmosis.
Topics: Adult; Amphotericin B; Antibody Formation; Female; Histoplasmosis; Humans; Immunity, Cellular; Mouth Diseases; Pharyngeal Diseases; Recurrence; Skin Manifestations; Sulfisoxazole | 1978 |
Extradural toruloma in the lumbo-sacral region.
Topics: Amphotericin B; Cryptococcosis; Humans; Lumbosacral Region; Male; Middle Aged; Spinal Diseases; Sulfisoxazole | 1975 |
Antimicrobial agents: pediatric dosage, routes of administration and preparation procedures for parenteral therapy.
Topics: Amphotericin B; Anti-Infective Agents; Bacitracin; Cephalothin; Chloramphenicol; Colistin; Erythromycin; Humans; Isoniazid; Kanamycin; Lincomycin; Neomycin; Nitrofurantoin; Novobiocin; Oleandomycin; Polymyxins; Streptomycin; Sulfadiazine; Sulfisoxazole; Tetracycline; Viomycin | 1968 |
Myocarditis associated with primary amebic (Naegleria) meningoencephalitis.
Topics: Adolescent; Adult; Amoeba; Amphotericin B; Brain; Bronchopneumonia; Child; Chloroquine; Electrocardiography; Emetine; Eosinophils; Exudates and Transudates; Female; Hepatitis; Humans; Male; Meningoencephalitis; Metronidazole; Myocarditis; Myocardium; Penicillins; Pulmonary Edema; Sulfadiazine; Sulfisoxazole | 1974 |
Pneumonia caused by Nocardia nova and Aspergillus fumigatus after cardiac transplantation.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Therapy, Combination; Heart Transplantation; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia; Nocardia Infections; Pneumonia; Postoperative Complications; Sulfisoxazole | 1993 |